{
  "catalogId": "2ca02e4c-8c2d-4691-9a6c-e21841e382db",
  "name": "ENTYVIO I.V.",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "153 58 34277 00",
  "treatmentDescriptions": "Ulcerative Colitis:Entyvio is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumour necrosis factor alpha (TNFα) antagonist.Crohn’s Disease:Entyvio is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumour necrosis factor alpha (TNFα) antagonist.Pouchitis Entyvio is indicated for the treatment of adult patients with moderately to severely active chronic pouchitis, who have undergone proctocolectomy and ileal pouch anal anastomosis for ulcerative colitis, and have had an inadequate response with or lost response to antibiotic therapy.",
  "termsOfIssue": "Prescription required",
  "form": "powder for concentrate for solution for infusion",
  "route": "i.v",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "VEDOLIZUMAB/VIAL",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L04AG05",
      "name": "VEDOLIZUMAB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "ENTYVIO 300 MG/VIAL",
      "manufacturer": {
        "name": "טקדה",
        "countryOfOrigin": "IL"
      },
      "strength": [
        {
          "value": 300.0,
          "unit": "mg/vial"
        }
      ],
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL GLASS TYPE I",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "7558",
        "yarpa": "66601",
        "pharmasoft": "5585",
        "barcode": "50335382011547"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 7850.055649,
        "retailMargin": 10.0,
        "maxRetailPrice": 8635.061214,
        "maxPriceWithVAT": 10189.37178
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T19:13:38.929975",
    "tags": [],
    "smartValidation": {
      "extractedFrom": "ENTYVIO 300 MG/VIAL",
      "processedBy": "smart_validation",
      "bestMatchScore": 0.008333333333333333,
      "status": "failed_match"
    },
    "aiResolution": {
      "resolvedAt": "2025-08-01T19:13:38.929984",
      "confidence": 95,
      "reasoning": "The medication name, ENTYVIO I.V., strength (300.0mg/vial), and registration number (153 58 34277 00) all match with the provided medication details.",
      "selectedOption": 1,
      "selectedRegistration": "153 58 34277 00",
      "method": "openai_gpt3.5_turbo"
    }
  }
}